Experience with ceftazidime-avibactam treatment in a tertiary care center in Saudi Arabia
- PMID: 29706317
- DOI: 10.1016/j.jiph.2018.04.013
Experience with ceftazidime-avibactam treatment in a tertiary care center in Saudi Arabia
Abstract
Introduction: Carbapenem-resistant organisms have become major healthcare-associated pathogens and are responsible for significant morbidity and mortality worldwide.
Cases and managements: This case-series describes our experience with ceftazidime-avibactam in the treatment of six cases with carbapenem-resistant organisms in King Abdulaziz Medical City in Riyadh, Saudi Arabia. After trying various combinations of antibiotic therapies without improvement, cases were treated with ceftazidime-avibactam.
Outcomes: Five of the six achieved complete cure, both clinically and microbiologically.
Keywords: Ceftazidime–avibactam; MDR-infections; Saudi Arabia.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
